Last Close
Apr 08  •  04:00PM ET
2.69
Dollar change
+0.11
Percentage change
4.26
%
Today, 3:10 PMEvotec SE posts Q4 2025 revenue growth, higher EBITDA and >EUR60m cost savings, highlights $650 million Sandoz biologics agreement
Index
-
P/E
-
EPS (ttm)
-0.50
Insider Own
5.17%
Shs Outstand
355.21M
Perf Week
7.60%
Market Cap
956.08M
Forward P/E
-
EPS next Y
-0.30
Insider Trans
0.00%
Shs Float
337.04M
Perf Month
-11.22%
Enterprise Value
1.25B
PEG
-
EPS next Q
0.18
Inst Own
3.24%
Perf Quarter
-19.70%
Income
-176.43M
P/S
1.15
EPS this Y
63.52%
Inst Trans
-2.32%
Perf Half Y
-32.58%
Sales
832.06M
P/B
1.02
EPS next Y
-28.48%
ROA
-8.20%
Perf YTD
-12.66%
Book/sh
2.65
P/C
3.43
EPS next 5Y
46.62%
ROE
-17.46%
52W High
4.80 -43.96%
Perf Year
-11.51%
Cash/sh
0.78
P/FCF
-
EPS past 3/5Y
- -
ROIC
-12.64%
52W Low
2.31 16.55%
Perf 3Y
-75.96%
EV/EBITDA
-
Sales past 3/5Y
5.68% 11.52%
Gross Margin
20.69%
Volatility
3.22% 3.34%
Perf 5Y
-85.78%
EV/Sales
1.50
EPS Y/Y TTM
5.08%
Oper. Margin
-18.48%
ATR (14)
0.12
Perf 10Y
42.14%
Quick Ratio
2.03
Sales Y/Y TTM
-1.20%
Profit Margin
-21.20%
RSI (14)
50.22
Current Ratio
2.12
EPS Q/Q
-15.39%
SMA20
8.84%
Beta
1.89
Debt/Eq
0.61
Sales Q/Q
-5.70%
SMA50
-11.89%
Rel Volume
0.67
Prev Close
2.58
Employees
-
LT Debt/Eq
0.48
SMA200
-22.82%
Avg Volume
141.68K
Price
2.69
IPO
Feb 05, 2004
Option/Short
No / Yes
Trades
Volume
94,681
Change
4.26%
Date Action Analyst Rating Change Price Target Change
Feb-03-26Initiated Berenberg Buy
Apr-24-25Upgrade Deutsche Bank Sell → Hold
Oct-07-24Downgrade Jefferies Buy → Hold
Aug-08-24Downgrade Deutsche Bank Hold → Sell
Jul-29-24Downgrade Morgan Stanley Overweight → Equal-Weight $15 → $6
Jul-11-24Downgrade Deutsche Bank Buy → Hold
Apr-12-24Upgrade Deutsche Bank Hold → Buy
Jan-18-24Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-23-23Upgrade Morgan Stanley Equal-Weight → Overweight $12 → $16
Jun-16-23Downgrade BofA Securities Buy → Neutral $13
Today 03:00PM
05:33AM
Apr-07-26 09:16AM
03:00AM
Apr-01-26 05:35AM
01:50AM Loading…
01:50AM
Mar-23-26 03:10AM
Mar-19-26 02:50AM
Mar-13-26 06:17AM
Mar-10-26 02:27PM
07:10AM
Jan-18-26 12:30PM
Jan-08-26 01:50AM
Jan-02-26 12:30AM
Dec-08-25 01:20AM
02:50AM Loading…
Dec-04-25 02:50AM
Nov-12-25 02:00AM
Nov-05-25 02:00AM
Nov-04-25 04:30PM
07:59AM
Oct-29-25 05:10AM
Oct-27-25 02:50AM
Oct-17-25 11:52AM
Aug-26-25 05:29PM
Aug-14-25 02:41AM
Aug-13-25 01:25AM
Aug-12-25 09:24AM
Aug-06-25 04:15AM
Aug-04-25 08:17PM
Jul-30-25 01:45AM
01:40AM Loading…
01:40AM
Jul-25-25 10:57PM
Jul-22-25 08:39PM
09:09AM
Jul-21-25 07:28PM
06:10AM
05:50AM
Jul-18-25 08:34PM
Jul-11-25 08:14PM
Jul-09-25 10:31AM
Jul-02-25 07:42PM
Jun-25-25 01:50AM
Jun-20-25 07:19PM
Jun-11-25 08:30PM
Jun-03-25 05:28PM
May-29-25 08:31PM
May-23-25 07:31PM
May-15-25 08:26PM
May-09-25 08:42PM
May-08-25 08:43PM
May-07-25 01:50AM
01:43AM
May-06-25 01:20AM
Apr-29-25 04:30AM
Apr-28-25 07:25PM
Apr-24-25 01:50AM
Apr-17-25 03:58PM
02:24PM
01:45AM
Apr-10-25 06:00AM
Apr-02-25 03:30PM
Mar-06-25 07:55PM
Mar-04-25 01:45AM
Feb-26-25 02:00AM
Jan-22-25 02:00AM
Dec-11-24 02:00AM
Nov-29-24 02:00AM
Nov-24-24 05:49PM
Nov-22-24 11:15AM
08:35AM
Nov-20-24 12:14AM
Nov-19-24 06:01PM
Nov-18-24 07:47PM
07:00AM
Nov-15-24 10:45PM
03:43PM
Nov-14-24 05:30PM
04:15PM
Nov-07-24 08:37AM
Nov-06-24 01:20AM
Nov-05-24 01:50AM
Nov-04-24 07:18PM
Oct-30-24 03:30AM
Oct-23-24 02:00AM
Sep-26-24 02:00AM
Sep-20-24 09:45AM
Sep-05-24 08:00AM
Sep-03-24 01:50AM
Aug-14-24 10:09PM
01:30AM
Aug-13-24 02:00AM
Aug-09-24 10:24AM
Aug-08-24 01:50AM
Aug-07-24 07:15AM
Aug-06-24 07:29PM
03:30PM
03:15PM
Jul-10-24 01:50AM
Jul-08-24 08:20AM
Jun-28-24 08:47PM
Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just-Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just-Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.